【ChiCTR1900023491】Mindfulness-based intervention for children/youth with internalizing problems and their families: a pilot study
ChiCTR1900023491
正在进行
/
/
/
2019-05-31
/
/
children/youths with internalizing problems
Mindfulness-based intervention for children/youth with internalizing problems and their families: a pilot study
Mindfulness-based intervention for children/youth with internalizing problems and their families: a pilot study
The objective of this pilot study is to examine the feasibility and acceptability of a mindfulness-based interventional program for children/youth with internalizing problems and their parents in Hong Kong, using wait list control and a pre-post design
随机平行对照
探索性研究/预试验
The randomisation will be conducted by an experienced independent statistician using computer-generated random results.
Not stated
The D. H. Chen Foundation, Hong Kong SAR
/
25
/
2019-07-04
2021-07-03
/
1) anxious/depressed, withdrawn/depressed, and somatic complains as shown with a high score in the Child Behavior Checklist; 2) have not participated in mindfulness program before; 3) and at least one of their parents agrees to participate.；
请登录查看The exclusion criteria will be: (1) being unable to communicate and understand Chinese language as the intervention will be conducted in Chinese; (2) having a medical condition rendering him/her to be incapable to participate in the study; (3) unwilling or unable to give consent.；
请登录查看The D. H. Chen Foundation, Hong Kong SAR
/
The D. H. Chen Foundation, Hong Kong SAR的其他临床试验
- Mindfulness-based intervention for children/youth with internalizing problems and their families: a pilot study
- Mindfulness based intervention for Chinese children with autism and their parents: a randomised controlled trial
- A randomised controlled trial comparing MYmind with waitlist control among Chinese children with ADHD and their parents
香港中文大學賽馬會公共衛生與基層醫療學院的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29